{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:07:41Z","timestamp":1790154461871,"version":"4.0.1"},"reference-count":205,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.humimm.2026.112045","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T16:29:28Z","timestamp":1787329768000},"page":"112045","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Alopecia areata: An autoimmune insult, molecular insights, and therapeutic horizons"],"prefix":"10.1016","volume":"87","author":[{"given":"Muhammad","family":"Usman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Touseef Ahmad","family":"Khattak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Fozan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.humimm.2026.112045_bb0005","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/exd.14155","article-title":"Hair follicle immune privilege and its collapse in alopecia areata","volume":"29","author":"Bertolini","year":"2020","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.humimm.2026.112045_bb0010","series-title":"The molecular basis of alopecia areata and risk assessment of comorbid autoimmune diseases","author":"Macgranaky-Quaye","year":"2022"},{"issue":"3","key":"10.1016\/j.humimm.2026.112045_bb0015","doi-asserted-by":"crossref","DOI":"10.1111\/cup.13864","article-title":"Alopecia areata-like pattern: a new unifying concept","volume":"48","author":"Thompson","year":"2021","journal-title":"J. Cutan. Pathol."},{"issue":"2","key":"10.1016\/j.humimm.2026.112045_bb0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10238-020-00673-w","article-title":"Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options","volume":"21","author":"Sterkens","year":"2021","journal-title":"Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0025","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jaad.2020.06.047","article-title":"Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: a systematic review","volume":"85","author":"Toussi","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"10.1016\/j.humimm.2026.112045_bb0030","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/bjd\/ljae058","article-title":"Global, regional and national epidemiology of alopecia areata: a systematic review and modelling study","volume":"191","author":"Jeon","year":"2024","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.humimm.2026.112045_bb0035","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.jaad.2019.06.1300","article-title":"Racial characteristics of alopecia areata in the United States","volume":"83","author":"Lee","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0040","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41380-021-01161-7","article-title":"Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies","volume":"27","author":"Solmi","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.humimm.2026.112045_bb0045","series-title":"Hair Disorders","first-page":"1","article-title":"Alopecia areata","author":"Messenger","year":"2021"},{"issue":"12","key":"10.1016\/j.humimm.2026.112045_bb0050","article-title":"Social anxiety disorder: associated conditions and therapeutic approaches","volume":"14","author":"Alomari","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.humimm.2026.112045_bb0055","unstructured":"Davey, L. (2020). Exploring the subjectivities of people with alopecia areata: a critical qualitative study to inform applied psychology practice University of the West of England Bristol]."},{"key":"10.1016\/j.humimm.2026.112045_bb0060","series-title":"A study of clinical and dermoscopic features in alopeica areata at a tertiary referral centre","author":"Nikhil","year":"2018"},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0065","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000510880","article-title":"Demographic and clinical features of 1,641 patients with alopecia areata, alopecia totalis, and alopecia universalis: a single-center retrospective study","volume":"7","author":"Uzuncakmak","year":"2021","journal-title":"Skin Appendage Disord."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0070","first-page":"84","article-title":"Sisaipho revisited: inverse Ophiasis or more than that?","volume":"11","author":"Katoulis","year":"2025","journal-title":"Skin Appendage Disord."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0075","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12016-017-8620-9","article-title":"Alopecia areata: a comprehensive review of pathogenesis and management","volume":"54","author":"Tr\u00fceb","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2026.112045_bb0080","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1517\/17460441.2015.1009892","article-title":"Drug discovery for alopecia: gone today, hair tomorrow","volume":"10","author":"Santos","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.humimm.2026.112045_bb0085","series-title":"Alopecia Areata-Current and Emerging Therapies University of Rijeka. Faculty of Medicine","author":"Sterk","year":"2024"},{"key":"10.1016\/j.humimm.2026.112045_bb0090","series-title":"Trichoscopic findings in alopecia areata and their relation to disease activity, severity and clinical subtype","author":"Bhandary","year":"2017"},{"issue":"3","key":"10.1016\/j.humimm.2026.112045_bb0095","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.mpdhp.2019.12.003","article-title":"Histopathologic diagnosis of alopecia: clues and pitfalls in the follicular microcosmos","volume":"26","author":"Stefanato","year":"2020","journal-title":"Diagn. Histopathol."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2017.11","article-title":"Alopecia areata","volume":"3","author":"Pratt","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"7","key":"10.1016\/j.humimm.2026.112045_bb0105","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3346\/jkms.2012.27.7.799","article-title":"Clinical characteristics and prognostic factors in early-onset alopecia totalis and alopecia universalis","volume":"27","author":"Cho","year":"2012","journal-title":"J. Korean Med. Sci."},{"issue":"7","key":"10.1016\/j.humimm.2026.112045_bb0110","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s13555-023-00941-z","article-title":"The invisible impact of a visible disease: psychosocial impact of alopecia areata","volume":"13","author":"Mesinkovska","year":"2023","journal-title":"Dermatol. Ther."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0115","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s00403-025-04093-2","article-title":"Illness perception, psychological distress, and quality of life in patients with alopecia: a cross-sectional study from Riyadh, Saudi Arabia","volume":"317","author":"Alotaibi","year":"2025","journal-title":"Arch. Dermatol. Res."},{"issue":"2","key":"10.1016\/j.humimm.2026.112045_bb0120","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jaad.2009.10.032","article-title":"Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis","volume":"62","author":"Alkhalifah","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.humimm.2026.112045_bb0125","series-title":"Physical activity, acceptance and mental health in people with alopecia areata: the use of a mixed-methods approach to inform an evidence-based intervention","author":"Rajoo","year":"2024"},{"issue":"3","key":"10.1016\/j.humimm.2026.112045_bb0130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jamadermatol.2022.6085","article-title":"Prevalence and odds of depressive and anxiety disorders and symptoms in children and adults with alopecia areata: a systematic review and meta-analysis","volume":"159","author":"Lauron","year":"2023","journal-title":"JAMA Dermatol."},{"issue":"3","key":"10.1016\/j.humimm.2026.112045_bb0135","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s13555-021-00512-0","article-title":"Patient perspectives of the social, emotional and functional impact of alopecia areata: a systematic literature review","volume":"11","author":"Mostaghimi","year":"2021","journal-title":"Dermatol. Ther."},{"issue":"2","key":"10.1016\/j.humimm.2026.112045_bb0140","doi-asserted-by":"crossref","DOI":"10.5070\/D329260765","article-title":"The psychosocial impacts of vitiligo, psoriasis, and alopecia areata on pediatric patients","volume":"29","author":"Cruz","year":"2023","journal-title":"Dermatol. Online J."},{"issue":"3","key":"10.1016\/j.humimm.2026.112045_bb0145","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3390\/jcm12030964","article-title":"Systematic review of psychological interventions for quality of life, mental health, and hair growth in alopecia areata and scarring alopecia","volume":"12","author":"Maloh","year":"2023","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.humimm.2026.112045_bb0150","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000485080","article-title":"Immune privilege collapse and alopecia development: is stress a factor","volume":"4","author":"Azzawi","year":"2018","journal-title":"Skin Appendage Disord."},{"key":"10.1016\/j.humimm.2026.112045_bb0155","series-title":"Investigating the mechanisms underlying the pathogenesis of alopecia areata","author":"Hamed","year":"2018"},{"issue":"2","key":"10.1016\/j.humimm.2026.112045_bb0160","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jdermsci.2010.09.006","article-title":"Hair follicle is a target of stress hormone and autoimmune reactions","volume":"60","author":"Ito","year":"2010","journal-title":"J. Dermatol. Sci."},{"issue":"4","key":"10.1016\/j.humimm.2026.112045_bb0165","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/med.21426","article-title":"Trends in regenerative medicine: repigmentation in vitiligo through melanocyte stem cell mobilization","volume":"37","author":"Birlea","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.humimm.2026.112045_bb0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/9781119476009.ch7","article-title":"Autoimmune skin disorders","author":"Satolli","year":"2019","journal-title":"Adv. Integr. Dermatol."},{"key":"10.1016\/j.humimm.2026.112045_bb0175","article-title":"From mechanisms to therapies: current advances and breakthroughs in alopecia Areata immunopathology","volume":"16","author":"Zhao","year":"2025","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2026.112045_bb0180","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF02934736","article-title":"Immunological tolerance and autoimmunity","volume":"1","author":"Romagnani","year":"2006","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.humimm.2026.112045_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1243556","article-title":"Inhibition of T-cell activity in alopecia areata: recent developments and new directions","volume":"14","author":"Passeron","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.112045_bb0190","doi-asserted-by":"crossref","unstructured":"Litvinov, I., Bizet, A., Binamer, Y., Jones, D., Sasseville, D., & Philip, A. (2011). CD109 function in human keratinocytes is linked to a psoriasis-like phenotype. J. Invest. Dermatol., 131, 20\u201325, J. Invest. Dermatol..","DOI":"10.1111\/j.1600-0625.2011.01288.x"},{"key":"10.1016\/j.humimm.2026.112045_bb0195","article-title":"Danger signaling through the inflammasome: a master switch between tolerance and sensitization to irritant chemicals","volume":"127","author":"Endothelin","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.humimm.2026.112045_bb0200","series-title":"Innate Immune System of Skin and Oral Mucosa: Properties and Impact in Pharmaceutics, Cosmetics, and Personal Care Products","first-page":"215","article-title":"Changes in Skin Immunity with Age and Disease","author":"Geusens","year":"2011"},{"issue":"14","key":"10.1016\/j.humimm.2026.112045_bb0205","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.3390\/ijms25147666","article-title":"Understanding autoimmunity: mechanisms, predisposing factors, and cytokine therapies","volume":"25","author":"Yasmeen","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.humimm.2026.112045_bb0210","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cmi.2017.43","article-title":"The IL-1R\/TLR signaling pathway is essential for efficient CD8+ T-cell responses against hepatitis B virus in the hydrodynamic injection mouse model","volume":"14","author":"Ma","year":"2017","journal-title":"Cell. Mol. Immunol."},{"issue":"9","key":"10.1016\/j.humimm.2026.112045_bb0215","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.humimm.2026.112045_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1565241","article-title":"Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata","volume":"16","author":"Gay-Mimbrera","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.112045_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1493308","article-title":"The current state of knowledge on the role of NKG2D ligands in multiple sclerosis and other autoimmune diseases","volume":"17","author":"Pogoda-Weso\u0142owska","year":"2025","journal-title":"Front. Mol. Neurosci."},{"issue":"5","key":"10.1016\/j.humimm.2026.112045_bb0230","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/cmi.2017.161","article-title":"Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapy","volume":"15","author":"Prajapati","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.humimm.2026.112045_bb0235","series-title":"The Role of IL-33 in Regulating Skin Immunity and Skin Carcinogenesis Imperial College London","author":"Ward","year":"2019"},{"key":"10.1016\/j.humimm.2026.112045_bb0240","series-title":"Genetic Mechanisms Controlling Human Hair Growth","author":"DeStefano","year":"2015"},{"key":"10.1016\/j.humimm.2026.112045_bb0245","article-title":"The role of NKG2D in vitiligo","volume":"12","author":"Plaza-Rojas","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.112045_bb0250","series-title":"The Role of NKT Cells Following Solid Organ Transplantation University of Manchester","author":"Gieschen-Krische","year":"2014"},{"key":"10.1016\/j.humimm.2026.112045_bb0255","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2147\/CCID.S309215","article-title":"A comprehensive literature review of JAK inhibitors in treatment of alopecia areata","author":"Dillon","year":"2021","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"issue":"4","key":"10.1016\/j.humimm.2026.112045_bb0260","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/14656566.2024.2333964","article-title":"Upadacitinib in Crohn\u2019s disease","volume":"25","author":"Dignass","year":"2024","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.humimm.2026.112045_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.955035","article-title":"An overview of JAK\/STAT pathways and JAK inhibition in alopecia areata","volume":"13","author":"Lensing","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.112045_bb0270","series-title":"JAK-STAT Signaling in Diseases","first-page":"9","article-title":"The structure-function bonhomie of JAK-STAT molecules","author":"Goswami","year":"2020"},{"issue":"3","key":"10.1016\/j.humimm.2026.112045_bb0275","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/bjd.14645","article-title":"Vasoactive intestinal peptide, whose receptor-mediated signalling may be defective in alopecia areata, provides protection from hair follicle immune privilege collapse","volume":"175","author":"Bertolini","year":"2016","journal-title":"Br. J. Dermatol."},{"issue":"12","key":"10.1016\/j.humimm.2026.112045_bb0280","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/pro.3519","article-title":"The molecular details of cytokine signaling via the JAK\/STAT pathway","volume":"27","author":"Morris","year":"2018","journal-title":"Protein Sci."},{"issue":"5","key":"10.1016\/j.humimm.2026.112045_bb0285","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70182","article-title":"Alopecia Areata: pathogenesis, diagnosis, and therapies","volume":"6","author":"Ma","year":"2025","journal-title":"MedComm"},{"issue":"5","key":"10.1016\/j.humimm.2026.112045_bb0290","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/jdv.19797","article-title":"Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: a systematic review and Bayesian network meta-analysis","volume":"38","author":"Husein-ElAhmed","year":"2024","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0295","first-page":"81","article-title":"Cutaneous lupus erythematosus: current and future pathogenesis-directed therapies","volume":"93","author":"Little","year":"2020","journal-title":"Yale J. Biol. Med."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0300","doi-asserted-by":"crossref","DOI":"10.4110\/in.2022.22.e7","article-title":"Immunopathology and immunotherapy of inflammatory skin diseases","volume":"22","author":"Song","year":"2022","journal-title":"Immune Netw."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0305","first-page":"23","article-title":"Mitochondrial dysfunction in lichen Planopilaris with focus on oxidative stress and metabolic reprogramming","volume":"11","author":"Mukarram","year":"2025","journal-title":"Int. J. Res."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0310","article-title":"Reactive oxygen species, oxidative damage, and antioxidative defense mechanism in plants under stressful conditions","volume":"2","author":"Sharma","year":"2012","journal-title":"Aust. J. Bot."},{"issue":"4","key":"10.1016\/j.humimm.2026.112045_bb0315","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/ijd.14753","article-title":"Oxidative stress in alopecia areata: a systematic review and meta-analysis","volume":"59","author":"Acharya","year":"2020","journal-title":"Int. J. Dermatol."},{"issue":"4","key":"10.1016\/j.humimm.2026.112045_bb0320","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1468-3083.2010.03799.x","article-title":"Lipid peroxidation\/antioxidant activity in patients with alopecia areata","volume":"25","author":"Abdel Fattah","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"7","key":"10.1016\/j.humimm.2026.112045_bb0325","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3390\/life13071433","article-title":"Markers of oxidative stress in patients with acne: a literature review","volume":"13","author":"Popa","year":"2023","journal-title":"Life"},{"issue":"8","key":"10.1016\/j.humimm.2026.112045_bb0330","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3390\/diagnostics10080601","article-title":"Oxidative stress markers in inflammatory bowel diseases: systematic review","volume":"10","author":"Krzystek-Korpacka","year":"2020","journal-title":"Diagnostics"},{"issue":"4","key":"10.1016\/j.humimm.2026.112045_bb0335","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0188-4409(01)00285-5","article-title":"Catalase\/superoxide dismutase (SOD) and catalase\/paraoxonase (PON) ratios may implicate poor glycemic control","volume":"32","author":"S\u00f6zmen","year":"2001","journal-title":"Arch. Med. Res."},{"issue":"Spec Issue","key":"10.1016\/j.humimm.2026.112045_bb0340","first-page":"43","article-title":"Oxidative stress and alopecia areata","volume":"8","author":"Prie","year":"2015","journal-title":"J. Med. Life"},{"issue":"12","key":"10.1016\/j.humimm.2026.112045_bb0345","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18486","article-title":"Oxidative stress in hair follicle development and hair growth: signalling pathways, intervening mechanisms and potential of natural antioxidants","volume":"28","author":"Du","year":"2024","journal-title":"J. Cell. Mol. Med."},{"issue":"261","key":"10.1016\/j.humimm.2026.112045_bb0350","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2003638","article-title":"Mitochondrial reactive oxygen species promote epidermal differentiation and hair follicle development","volume":"6","author":"Hamanaka","year":"2013","journal-title":"Sci. Signal."},{"issue":"10","key":"10.1016\/j.humimm.2026.112045_bb0355","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1101\/gad.262758.115","article-title":"The three \u2018P\u2019s of mitophagy: PARKIN, PINK1, and post-translational modifications","volume":"29","author":"Durcan","year":"2015","journal-title":"Genes Dev."},{"issue":"3","key":"10.1016\/j.humimm.2026.112045_bb0360","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s12016-021-08883-0","article-title":"Alopecia areata: an update on etiopathogenesis, diagnosis, and management","volume":"61","author":"Zhou","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"12","key":"10.1016\/j.humimm.2026.112045_bb0365","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.3390\/ijerph15122882","article-title":"Epigallocatechin-3 gallate inhibits stat-1\/jak2\/irf-1\/hla-dr\/hla-b and reduces cd8 mkg2d lymphocytes of alopecia areata patients","volume":"15","author":"Hamed","year":"2018","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.humimm.2026.112045_bb0370","series-title":"The Immunogenetics of Dermatologic Diseases","first-page":"19","article-title":"The immunogenetics of alopecia areata","author":"Rajabi","year":"2022"},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0375","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/antiox12010135","article-title":"Alopecia areata: a review of the role of oxidative stress, possible biomarkers, and potential novel therapeutic approaches","volume":"12","author":"Peterle","year":"2023","journal-title":"Antioxidants"},{"issue":"10","key":"10.1016\/j.humimm.2026.112045_bb0380","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1080\/1744666X.2025.2575365","article-title":"Immune therapies for alopecia areata: evidence and new perspectives","volume":"21","author":"Lai","year":"2025","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0385","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1089\/jir.2022.0198","article-title":"Counteracting interleukin-15 to elucidate its modes of action in physiology and pathology","volume":"43","author":"Mortier","year":"2023","journal-title":"J. Interf. Cytokine Res."},{"issue":"14","key":"10.1016\/j.humimm.2026.112045_bb0390","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd1866","article-title":"Blockade of IL-7 signaling suppresses inflammatory responses and reverses alopecia areata in C3H\/HeJ mice","volume":"7","author":"Dai","year":"2021","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0395","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.det.2024.09.001","article-title":"Innovation in alopecia areata","volume":"43","author":"Kalil","year":"2025","journal-title":"Dermatol. Clin."},{"issue":"46","key":"10.1016\/j.humimm.2026.112045_bb0400","doi-asserted-by":"crossref","first-page":"17414","DOI":"10.1073\/pnas.0605136103","article-title":"Kv1. 3 channels are a therapeutic target for T cell-mediated autoimmune diseases","volume":"103","author":"Beeton","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.humimm.2026.112045_bb0405","article-title":"NLRP3 inflammasome: checkpoint connecting innate and adaptive immunity in autoimmune diseases","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0410","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2025.2561223","article-title":"Next-generation immunotherapies for head and neck squamous cell carcinoma: targeting novel immune checkpoints","volume":"57","author":"Tang","year":"2025","journal-title":"Ann. Med."},{"issue":"3","key":"10.1016\/j.humimm.2026.112045_bb0415","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/all.15071","article-title":"Phase 2a randomized clinical trial of dupilumab (anti-IL-4R\u03b1) for alopecia areata patients","volume":"77","author":"Guttman-Yassky","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.humimm.2026.112045_bb0420","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1641918","article-title":"Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment","volume":"16","author":"Cheng","year":"2025","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.humimm.2026.112045_bb0425","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/1744666X.2022.2096590","article-title":"Translational impact of omics studies in alopecia areata: recent advances and future perspectives","volume":"18","author":"Basmanav","year":"2022","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0430","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40709-019-0094-x","article-title":"A systematic simulation-based meta-analytical framework for prediction of physiological biomarkers in alopecia","volume":"26","author":"Muhammad","year":"2019","journal-title":"J. Biol. Res.-Thessalon."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0435","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41421-022-00394-2","article-title":"Single-cell transcriptomics reveals lineage trajectory of human scalp hair follicle and informs mechanisms of hair graying","volume":"8","author":"Wu","year":"2022","journal-title":"Cell Discov."},{"key":"10.1016\/j.humimm.2026.112045_bb0440","series-title":"Activity of Nrf2 in the human hair follicle: understanding Dkk-1 and mast cells regulation by Nrf2","author":"Jadkauskaite","year":"2017"},{"key":"10.1016\/j.humimm.2026.112045_bb0445","series-title":"British Society for Investigative Dermatology Annual Meeting 2018 26\u201328 March 2018 Blizard Institute","author":"McMenemy","year":"2018"},{"issue":"8","key":"10.1016\/j.humimm.2026.112045_bb0450","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/exd.13756","article-title":"Corneocyte proteomics: applications to skin biology and dermatology","volume":"27","author":"Rice","year":"2018","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.humimm.2026.112045_bb0455","series-title":"Keratin","article-title":"Human hair as a testing substrate in the era of precision medicine: potential role of \u2018omics-based approaches","author":"Adeola","year":"2018"},{"key":"10.1016\/j.humimm.2026.112045_bb0460","series-title":"Protein biomarkers: discovery and applications in clinical diagnostics","author":"Singh","year":"2024"},{"key":"10.1016\/j.humimm.2026.112045_bb0465","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2025.1635202","article-title":"Multi-omics and AI-driven advances in miRNA-mediated hair follicle regulation in cashmere goats","volume":"12","author":"Chunhua","year":"2025","journal-title":"Front. Vet. Sci."},{"issue":"2","key":"10.1016\/j.humimm.2026.112045_bb0470","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.tig.2021.08.012","article-title":"Intricacies of single-cell multi-omics data integration","volume":"38","author":"Rautenstrauch","year":"2022","journal-title":"Trends Genet."},{"issue":"8","key":"10.1016\/j.humimm.2026.112045_bb0475","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1111\/all.16659","article-title":"Multiomics analysis of the response to ritlecitinib in alopecia areata subtypes and correlation with efficacy","volume":"80","author":"Xi","year":"2025","journal-title":"Allergy"},{"key":"10.1016\/j.humimm.2026.112045_bb0480","series-title":"British society for investigative dermatology virtual annual meeting, 29\u201331 March 2021","author":"Mukhtar","year":"2021"},{"issue":"4","key":"10.1016\/j.humimm.2026.112045_bb0485","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1529-8019.2001.01041.x","article-title":"The genetics of alopecia areata","volume":"14","author":"Aita","year":"2001","journal-title":"Dermatol. Ther."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0490","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jgc4.1178","article-title":"Familial implications of autoimmune disease: recurrence risks of alopecia areata and associated conditions in first-degree relatives","volume":"29","author":"Agre","year":"2020","journal-title":"J. Genet. Couns."},{"issue":"03","key":"10.1016\/j.humimm.2026.112045_bb0495","first-page":"112","article-title":"The human leukocyte antigen and genetic susceptibility in human diseases","volume":"2","author":"Gao","year":"2019","journal-title":"J. Bio-X Res."},{"key":"10.1016\/j.humimm.2026.112045_bb0500","first-page":"1","article-title":"Meta-analysis of gene expression reveals the core transcriptomic profile of lesional scalp in alopecia areata","author":"Rivera-Ruiz","year":"2025","journal-title":"Dermatol. Ther."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0505","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/s41467-022-28343-3","article-title":"Whole exome sequencing in alopecia Areata identifies rare variants in KRT82","volume":"13","author":"Erjavec","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0510","doi-asserted-by":"crossref","first-page":"10074","DOI":"10.1038\/s41598-018-28423-9","article-title":"CTLA-4+ 49 G\/A, a functional T1D risk SNP, affects CTLA-4 level in Treg subsets and IA-2A positivity, but not beta-cell function","volume":"8","author":"Chen","year":"2018","journal-title":"Sci. Rep."},{"issue":"91","key":"10.1016\/j.humimm.2026.112045_bb0515","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adh0152","article-title":"Regulatory T cells in skin mediate immune privilege of the hair follicle stem cell niche","volume":"9","author":"Cohen","year":"2024","journal-title":"Sci. Immunol."},{"issue":"7302","key":"10.1016\/j.humimm.2026.112045_bb0520","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature09114","article-title":"Genome-wide association study in alopecia areata implicates both innate and adaptive immunity","volume":"466","author":"Petukhova","year":"2010","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.humimm.2026.112045_bb0525","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nrendo.2013.161","article-title":"Clinical implications of shared genetics and pathogenesis in autoimmune diseases","volume":"9","author":"Zhernakova","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.humimm.2026.112045_bb0530","first-page":"89","article-title":"Targeting inflammation and immune activation. JAK inhibition in autoimmune and inflammatory diseases","volume":"16648714","author":"Iglesias","year":"2023"},{"key":"10.1016\/j.humimm.2026.112045_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2023.341973","article-title":"A point-of-care platform for hair loss-related single nucleotide polymorphism genotyping","volume":"1283","author":"Thai","year":"2023","journal-title":"Anal. Chim. Acta"},{"issue":"5","key":"10.1016\/j.humimm.2026.112045_bb0540","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/cosmetics12050190","article-title":"26-SNP panel aids guiding androgenetic alopecia therapy and provides insight into mechanisms of action","volume":"12","author":"Gaboardi","year":"2025","journal-title":"Cosmetics"},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0545","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/157488406775268183","article-title":"Pharmacokinetics and metabolic drug interactions","volume":"1","author":"Leucuta","year":"2006","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.humimm.2026.112045_bb0550","series-title":"Goodman and Gilman\u2019s. The Pharmacological Basis of Therapeutics","first-page":"71","article-title":"Drug metabolism","author":"Gonzalez","year":"2006"},{"key":"10.1016\/j.humimm.2026.112045_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2022.105942","article-title":"Hair cortisol, glucocorticoid gene receptor polymorphisms, stress, and testicular function","volume":"146","author":"Nordkap","year":"2022","journal-title":"Psychoneuroendocrinology"},{"issue":"11","key":"10.1016\/j.humimm.2026.112045_bb0560","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1507\/endocrj.EJ18-0135","article-title":"Glucocorticoid resistance syndrome caused by a novel NR3C1 point mutation","volume":"65","author":"Al Argan","year":"2018","journal-title":"Endocr. J."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0565","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12911-025-02853-8","article-title":"Identifying effective immune biomarkers in alopecia areata diagnosis based on machine learning methods","volume":"25","author":"Zhou","year":"2025","journal-title":"BMC Med. Inform. Decis. Mak."},{"key":"10.1016\/j.humimm.2026.112045_bb0570","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ebiom.2016.03.036","article-title":"Molecular signatures define alopecia areata subtypes and transcriptional biomarkers","volume":"7","author":"Jabbari","year":"2016","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.humimm.2026.112045_bb0575","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1111\/jocd.14473","article-title":"Diagnostic implications of MicroRNAs; 155, 146 a, and 203 lesional expression in alopecia areata: a preliminary case-controlled study","volume":"21","author":"Mustafa","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.humimm.2026.112045_bb0580","first-page":"4103","article-title":"Insights into the impact of artificial intelligence on psoriasis treatment strategies: a mini review","volume":"10","author":"Prithiviraj","year":"2025","journal-title":"Indian Dermatol. Online J."},{"issue":"15","key":"10.1016\/j.humimm.2026.112045_bb0585","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.3390\/cancers15153837","article-title":"Precision medicine: disease subtyping and tailored treatment","volume":"15","author":"Wang","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.humimm.2026.112045_bb0590","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/antib14030079","article-title":"Monoclonal antibodies and small-molecule therapies for lichen planus: targeted immunomodulation and emerging evidence","volume":"14","author":"Rosset","year":"2025","journal-title":"Antibodies"},{"issue":"4","key":"10.1016\/j.humimm.2026.112045_bb0595","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s12033-024-01133-6","article-title":"From data to cure: a comprehensive exploration of multi-omics data analysis for targeted therapies","volume":"67","author":"Mukherjee","year":"2025","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.humimm.2026.112045_bb0600","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.570672","article-title":"Using gene editing approaches to fine-tune the immune system","volume":"11","author":"Pavlovic","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0605","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/immuno5010006","article-title":"Advances in synthetic immunology for targeted treatment of systemic autoimmune diseases: opportunities, challenges, and future directions","volume":"5","author":"Adytia","year":"2025","journal-title":"Immuno"},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0610","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/HRP.10.1097\/HRP.0000000000000005","article-title":"Strategies to predict, measure, and improve psychosocial treatment adherence","volume":"22","author":"Gearing","year":"2014","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.humimm.2026.112045_bb0615","series-title":"The Immunopathogenesis of Alopecia Areata","author":"Bain","year":"2020"},{"key":"10.1016\/j.humimm.2026.112045_bb0620","doi-asserted-by":"crossref","unstructured":"J.I. Kosten,Rustemeyer, T. (2014). Generation, subsets and functions of inducible regulatory T cells. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistryrrent Medicinal Chemistry-Anti-Inflammatory and Anti-Allergy Agents), 13(3), 139\u2013153.","DOI":"10.2174\/1871523013666141126100019"},{"issue":"2","key":"10.1016\/j.humimm.2026.112045_bb0625","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1250","article-title":"Natural killer cells in inflammatory autoimmune diseases","volume":"10","author":"Yang","year":"2021","journal-title":"Clin. Transl. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2026.112045_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103257","article-title":"Research advances on targeted-Treg therapies on immune-mediated kidney diseases","volume":"22","author":"Li","year":"2023","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0635","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/ijt.ijt_28_21","article-title":"An updated review on current treatment of alopecia Areata and newer therapeutic options","volume":"15","author":"Malhotra","year":"2023","journal-title":"Int. J. Trichology"},{"key":"10.1016\/j.humimm.2026.112045_bb0640","unstructured":"Marques, M., & Correia, T. Adverse Drug Reactions."},{"issue":"7","key":"10.1016\/j.humimm.2026.112045_bb0645","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1080\/09553002.2021.1928782","article-title":"RENEB inter-laboratory comparison 2017: limits and pitfalls of ILCs","volume":"97","author":"Gregoire","year":"2021","journal-title":"Int. J. Radiat. Biol."},{"issue":"7","key":"10.1016\/j.humimm.2026.112045_bb0650","first-page":"499","article-title":"Corticosteroids for alopecia areata in children","volume":"66","author":"Fernando","year":"2020","journal-title":"Can. Fam. Physician"},{"issue":"10","key":"10.1016\/j.humimm.2026.112045_bb0655","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1007\/s13555-023-00991-3","article-title":"Diagnosis and management of alopecia areata: a Saudi expert consensus statement (2023)","volume":"13","author":"Fatani","year":"2023","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.humimm.2026.112045_bb0660","series-title":"Nijkamp and Parnham\u2019s Principles of Immunopharmacology","first-page":"661","article-title":"Corticosteroids","author":"Caramori","year":"2019"},{"key":"10.1016\/j.humimm.2026.112045_bb0665","unstructured":"Kansal, S. Assessment of dermatological changes in patients receiving long-term corticosteroid therapy."},{"issue":"6","key":"10.1016\/j.humimm.2026.112045_bb0670","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s13659-020-00267-9","article-title":"A systemic review on topical marketed formulations, natural products, and oral supplements to prevent androgenic alopecia: a review","volume":"10","author":"Ashique","year":"2020","journal-title":"Nat. Prod. Bioprospect."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0675","first-page":"7","article-title":"Effects of oral minoxidil on serum VEGF and hair regrowth in androgenetic alopecia","volume":"34","author":"Kawen","year":"2025","journal-title":"Acta dermatovenerologica Alpina, Pannonica, et Adriatica"},{"issue":"18","key":"10.1016\/j.humimm.2026.112045_bb0680","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.3390\/jcm10184257","article-title":"Systemic minoxidil accidental exposure in a paediatric population: a case series study of cutaneous and systemic side effects","volume":"10","author":"S\u00e1nchez-D\u00edaz","year":"2021","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.humimm.2026.112045_bb0685","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/187153012802002901","article-title":"Classical to current approach for treatment of psoriasis: a review","volume":"12","author":"Rahman","year":"2012","journal-title":"Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders)"},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0690","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0190-9622(84)80046-8","article-title":"Anthralin for psoriasis: short-contact anthralin therapy compared with topical steroid and conventional anthralin","volume":"10","author":"Lowe","year":"1984","journal-title":"J. Am. Acad. Dermatol."},{"issue":"6","key":"10.1016\/j.humimm.2026.112045_bb0695","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1159\/000518042","article-title":"A retrospective study on alopecia areata in children: clinical characteristics and treatment choices","volume":"7","author":"Stefanaki","year":"2021","journal-title":"Skin Appendage Disord."},{"issue":"3","key":"10.1016\/j.humimm.2026.112045_bb0700","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1365-2133.1999.03040.x","article-title":"The irritancy of anthralin is inhibited by repeat applications of a subirritant concentration","volume":"141","author":"Parslew","year":"1999","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0705","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s13555-018-0226-5","article-title":"Topical immunotherapy of alopecia areata: a large retrospective study","volume":"8","author":"Zerbinati","year":"2018","journal-title":"Dermatol. Ther."},{"issue":"6","key":"10.1016\/j.humimm.2026.112045_bb0710","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4103\/1947-2714.185029","article-title":"Comparative study of efficacy and safety of topical squaric acid dibutylester and diphenylcyclopropenone for the treatment of alopecia areata","volume":"8","author":"Tiwary","year":"2016","journal-title":"N. Am. J. Med. Sci."},{"issue":"4","key":"10.1016\/j.humimm.2026.112045_bb0715","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jaad.2015.01.008","article-title":"Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series","volume":"72","author":"Durdu","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.humimm.2026.112045_bb0720","article-title":"The efficacy and adverse effects of corticosteroid pulse therapy in alopecia areata: a review article","volume":"13","author":"Rastaghi","year":"2023","journal-title":"Dermatol. Pract. Concept."},{"key":"10.1016\/j.humimm.2026.112045_bb0725","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/pde.15822","article-title":"Systemic therapies for pediatric alopecia Areata","volume":"42","author":"Kalil","year":"2025","journal-title":"Pediatr. Dermatol."},{"issue":"6","key":"10.1016\/j.humimm.2026.112045_bb0730","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jaad.2010.02.063","article-title":"The use of cyclosporine in dermatology: part I","volume":"63","author":"Amor","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"issue":"5","key":"10.1016\/j.humimm.2026.112045_bb0735","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/pde.15327","article-title":"Methotrexate for inflammatory skin disease in pediatric patients: consensus treatment guidelines","volume":"40","author":"Siegfried","year":"2023","journal-title":"Pediatr. Dermatol."},{"issue":"2","key":"10.1016\/j.humimm.2026.112045_bb0740","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/1346-8138.17064","article-title":"Alopecia areata: what\u2019s new in the diagnosis and treatment with JAK inhibitors?","volume":"51","author":"Dainichi","year":"2024","journal-title":"J. Dermatol."},{"issue":"9","key":"10.1016\/j.humimm.2026.112045_bb0745","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s40265-023-01873-w","article-title":"Baricitinib for the treatment of alopecia areata","volume":"83","author":"Freitas","year":"2023","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0750","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12911-025-02853-8","article-title":"Identifying effective immune biomarkers in alopecia areata diagnosis based on machine learning methods","volume":"25","author":"Zhou","year":"2025","journal-title":"BMC Med. Inform. Decis. Mak."},{"key":"10.1016\/j.humimm.2026.112045_bb0755","article-title":"Selective expansion of Tregs using the IL-2 cytokine antibody complex does not reverse established alopecia Areata in C3H\/HeJ mice","volume":"13","author":"Lee","year":"2022","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.humimm.2026.112045_bb0760","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/lsm.23210","article-title":"Efficacy and influence factors of 308-nm excimer lamp with minoxidil in the treatment of alopecia areata","volume":"52","author":"Li","year":"2020","journal-title":"Lasers Surg. Med."},{"issue":"4","key":"10.1016\/j.humimm.2026.112045_bb0765","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4103\/0019-5154.113954","article-title":"308-nm excimer lamp for the treatment of alopecia areata: clinical trial on 16 cases","volume":"58","author":"Ohtsuki","year":"2013","journal-title":"Indian J. Dermatol."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0770","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/00029157.2017.1419457","article-title":"Mindfulness-based cognitive hypnotherapy and skin disorders","volume":"61","author":"Shenefelt","year":"2018","journal-title":"Am. J. Clin. Hypn."},{"issue":"5","key":"10.1016\/j.humimm.2026.112045_bb0775","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.cpr.2011.03.006","article-title":"Technological adjuncts to increase adherence to therapy: a review","volume":"31","author":"Clough","year":"2011","journal-title":"Clin. Psychol. Rev."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0780","doi-asserted-by":"crossref","DOI":"10.3390\/medicina61010153","article-title":"Enhancing therapy adherence: impact on clinical outcomes, healthcare costs, and patient quality of life","volume":"61","author":"Religioni","year":"2025","journal-title":"Medicina"},{"issue":"2","key":"10.1016\/j.humimm.2026.112045_bb0785","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/cosmetics11020055","article-title":"Wigs and alopecia Areata: psychosocial impact and economic considerations","volume":"11","author":"Courtney","year":"2024","journal-title":"Cosmetics"},{"issue":"3","key":"10.1016\/j.humimm.2026.112045_bb0790","doi-asserted-by":"crossref","first-page":"ojab015","DOI":"10.1093\/asjof\/ojab015","article-title":"Applications of medical tattooing: a systematic review of patient satisfaction outcomes and emerging trends","volume":"3","author":"Becker","year":"2021","journal-title":"Aesthet. Surg. J. Open Forum"},{"key":"10.1016\/j.humimm.2026.112045_bb0795","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.633436","article-title":"Regulatory dendritic cells, T cell tolerance, and dendritic cell therapy for immunologic disease","volume":"12","author":"Ness","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.112045_bb0800","series-title":"Techniques in the Evaluation and Management of Hair Diseases","first-page":"71","article-title":"Topical contact immunotherapy in alopecia Areata","author":"Combalia","year":"2021"},{"issue":"11","key":"10.1016\/j.humimm.2026.112045_bb0805","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/1346-8138.13933","article-title":"Management of alopecia areata: updates and algorithmic approach","volume":"44","author":"Lee","year":"2017","journal-title":"J. Dermatol."},{"issue":"8","key":"10.1016\/j.humimm.2026.112045_bb0810","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/ijd.13612","article-title":"Review of treatment for alopecia totalis and alopecia universalis","volume":"56","author":"Kassira","year":"2017","journal-title":"Int. J. Dermatol."},{"issue":"12","key":"10.1016\/j.humimm.2026.112045_bb0815","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00431-016-2781-z","article-title":"Moving toward a paradigm shift in the regulatory requirements for pediatric medicines","volume":"175","author":"Chin","year":"2016","journal-title":"Eur. J. Pediatr."},{"issue":"10","key":"10.1016\/j.humimm.2026.112045_bb0820","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.3390\/pharmaceutics15102431","article-title":"Pediatric drug development: reviewing challenges and opportunities by tracking innovative therapies","volume":"15","author":"Domingues","year":"2023","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.humimm.2026.112045_bb0825","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/healthcare5030044","article-title":"Interventions to support integrated psychological care and holistic health outcomes in paediatrics","volume":"5","author":"Shafran","year":"2017","journal-title":"Healthcare"},{"key":"10.1016\/j.humimm.2026.112045_bb0830","series-title":"Immunological disorders in mice","first-page":"153","article-title":"C3H\/HeJ mice","author":"V\u011btvi\u010dka","year":"1990"},{"issue":"10","key":"10.1016\/j.humimm.2026.112045_bb0835","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1600-0625.2008.00773.x","article-title":"The C3H\/HeJ mouse and DEBR rat models for alopecia areata: review of preclinical drug screening approaches and results","volume":"17","author":"Sun","year":"2008","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.humimm.2026.112045_bb0840","series-title":"Disease Mechanisms in the C3H\/HeJ Mouse Model of Alopecia","author":"Barekatain","year":"2008"},{"issue":"5","key":"10.1016\/j.humimm.2026.112045_bb0845","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.0022-202X.2005.23692.x","article-title":"Transfer of CD8+ cells induces localized hair loss whereas CD4+\/CD25\u2212 cells promote systemic alopecia areata and CD4+\/CD25+ cells blockade disease onset in the C3H\/HeJ mouse model","volume":"124","author":"McElwee","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.humimm.2026.112045_bb0850","series-title":"IL-15 and IFN-g Regulation in Murine NK Cells","author":"Cimpean","year":"2023"},{"key":"10.1016\/j.humimm.2026.112045_bb0855","series-title":"British Society for Investigative Dermatology Annual","author":"Ross","year":"2019"},{"issue":"3","key":"10.1016\/j.humimm.2026.112045_bb0860","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41571-022-00721-2","article-title":"Humanized mouse models for immuno-oncology research","volume":"20","author":"Chuprin","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.humimm.2026.112045_bb0865","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s11626-020-00513-x","article-title":"The microfollicle: a model of the human hair follicle for in vitro studies","volume":"56","author":"Ata\u00e7","year":"2020","journal-title":"In Vitro Cell. Dev. Biol. Animal"},{"issue":"6","key":"10.1016\/j.humimm.2026.112045_bb0870","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.199","article-title":"Modeling the pharmacokinetic-pharmacodynamic relationship of the monoclonal anti-macaque-IL-15 antibody Hu714Mu XH u in cynomolgus monkeys","volume":"3","author":"Pan","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"issue":"3","key":"10.1016\/j.humimm.2026.112045_bb0875","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3390\/ijms23031337","article-title":"Genome editing using CRISPR-Cas9 and autoimmune diseases: a comprehensive review","volume":"23","author":"Lee","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.humimm.2026.112045_bb0880","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.3390\/biomedicines11102621","article-title":"Small molecule targeting immune cells: a novel approach for cancer treatment","volume":"11","author":"Singh","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.humimm.2026.112045_bb0885","first-page":"1","article-title":"Biosensors for human cell analysis: immune cell dynamics and diagnostic capabilities","author":"Frumento","year":"2025","journal-title":"Biomed. Mater. Devices"},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0890","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13578-016-0098-2","article-title":"IL-15 signaling promotes adoptive effector T-cell survival and memory formation in irradiation-induced lymphopenia","volume":"6","author":"Xu","year":"2016","journal-title":"Cell Biosci."},{"issue":"3","key":"10.1016\/j.humimm.2026.112045_bb0895","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10067-018-4340-7","article-title":"Remission rate and predictors of remission in patients with rheumatoid arthritis under treat-to-target strategy in real-world studies: a systematic review and meta-analysis","volume":"38","author":"Yu","year":"2019","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb0900","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev-pathol-052016-100332","article-title":"Humanized mouse models of clinical disease","volume":"12","author":"Walsh","year":"2017","journal-title":"Annu. Rev. Pathol.: Mech. Dis."},{"issue":"11","key":"10.1016\/j.humimm.2026.112045_bb0905","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nri3311","article-title":"Humanized mice for immune system investigation: progress, promise and challenges","volume":"12","author":"Shultz","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.humimm.2026.112045_bb0910","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3810\/pgm.2011.09.2475","article-title":"Key concepts of clinical trials: a narrative review","volume":"123","author":"Umscheid","year":"2011","journal-title":"Postgrad. Med."},{"issue":"4","key":"10.1016\/j.humimm.2026.112045_bb0915","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/17512433.2023.2193682","article-title":"JAK inhibitors in dermatology: the road travelled and path ahead, a narrative review","volume":"16","author":"Muddebihal","year":"2023","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.humimm.2026.112045_bb0920","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s12325-017-0542-7","article-title":"The changing landscape of alopecia areata: the therapeutic paradigm","volume":"34","author":"Renert-Yuval","year":"2017","journal-title":"Adv. Ther."},{"key":"10.1016\/j.humimm.2026.112045_bb0925","article-title":"Janus kinase inhibitors for alopecia areata: a review of clinical data","volume":"16","author":"Sun","year":"2025","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.humimm.2026.112045_bb0930","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1007\/s13555-023-01044-5","article-title":"Treatments for moderate-to-severe alopecia areata: a systematic narrative review","volume":"13","author":"Egeberg","year":"2023","journal-title":"Dermatol. Ther."},{"issue":"3","key":"10.1016\/j.humimm.2026.112045_bb0935","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s40257-023-00764-w","article-title":"Efficacy and safety of Baricitinib in patients with severe alopecia Areata over 52 weeks of continuous therapy in two phase III trials (BRAVE-AA1 and BRAVE-AA2)","volume":"24","author":"Kwon","year":"2023","journal-title":"Am. J. Clin. Dermatol."},{"issue":"12","key":"10.1016\/j.humimm.2026.112045_bb0940","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nrd.2017.201","article-title":"JAK inhibition as a therapeutic strategy for immune and inflammatory diseases","volume":"16","author":"Schwartz","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.humimm.2026.112045_bb0945","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/14728214.2022.2149735","article-title":"Emerging drugs for the treatment of alopecia areata","volume":"27","author":"Ram\u00edrez-Mar\u00edn","year":"2022","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"7","key":"10.1016\/j.humimm.2026.112045_bb0950","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s00403-024-03182-y","article-title":"Ritlecitinib, a JAK3\/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo","volume":"316","author":"Yamaguchi","year":"2024","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.humimm.2026.112045_bb0955","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-1-4615-0171-8_6","article-title":"Cytokines in the treatment and prevention of autoimmune responses-a role of IL-15","volume":"520","author":"Zheng","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"issue":"11","key":"10.1016\/j.humimm.2026.112045_bb0960","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/nm.3962","article-title":"Hair follicle\u2013derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma","volume":"21","author":"Adachi","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.humimm.2026.112045_bb0965","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.702776","article-title":"A review of the efficacy and safety for biologic agents targeting IL-23 in treating psoriasis with the focus on tildrakizumab","volume":"8","author":"Ghazawi","year":"2021","journal-title":"Front. Med."},{"issue":"24","key":"10.1016\/j.humimm.2026.112045_bb0970","doi-asserted-by":"crossref","first-page":"17545","DOI":"10.3390\/ijms242417545","article-title":"The role of NKG2D and its ligands in autoimmune diseases: new targets for immunotherapy","volume":"24","author":"Wei","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.humimm.2026.112045_bb0975","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180088","article-title":"T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab","volume":"12","author":"Bughani","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2026.112045_bb0980","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2025.100282","article-title":"The AhR pathway is dysregulated in alopecia areata","volume":"10","author":"Belpaire","year":"2025","journal-title":"J. Transl. Autoimmunity"},{"issue":"4","key":"10.1016\/j.humimm.2026.112045_bb0985","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3390\/ijms26041618","article-title":"The aryl hydrocarbon receptor (AHR): peacekeeper of the skin","volume":"26","author":"Dawe","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.humimm.2026.112045_bb0990","doi-asserted-by":"crossref","first-page":"190","DOI":"10.5021\/ad.22.168","article-title":"Guidelines for the management of patients with alopecia areata in Korea: part I topical and device-based treatment","volume":"35","author":"Park","year":"2023","journal-title":"Ann. Dermatol."},{"issue":"11","key":"10.1016\/j.humimm.2026.112045_bb0995","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1080\/17460441.2024.2409660","article-title":"Innovative strategies for the discovery of new drugs against alopecia areata: taking aim at the immune system","volume":"19","author":"Guo","year":"2024","journal-title":"Expert Opin. Drug Discov."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb1000","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.det.2019.08.004","article-title":"How it works: the immunology underlying phototherapy","volume":"38","author":"Yu","year":"2020","journal-title":"Dermatol. Clin."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb1005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41423-019-0291-4","article-title":"Tissue-resident memory T cells and their biological characteristics in the recurrence of inflammatory skin disorders","volume":"17","author":"Chen","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2026.112045_bb1010","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jid.2020.08.015","article-title":"Low-dose IL-2 for treating moderate to severe alopecia areata: a 52-week multicenter prospective placebo-controlled study assessing its impact on T regulatory cell and NK cell populations","volume":"141","author":"Le Duff","year":"2021","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.humimm.2026.112045_bb1015","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.autrev.2013.09.008","article-title":"Tolerogenic dendritic cell vaccines to treat autoimmune diseases: can the unattainable dream turn into reality?","volume":"13","author":"Van Brussel","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.humimm.2026.112045_bb1020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrclinonc.2016.96","article-title":"Combine and conquer: challenges for targeted therapy combinations in early phase trials","volume":"14","author":"Lopez","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.humimm.2026.112045_bb1025","doi-asserted-by":"crossref","DOI":"10.1002\/der2.70008","article-title":"Alopecia Areata treatment: past, present, and future","volume":"5","author":"Jolkovsky","year":"2024","journal-title":"Dermatol. Rev."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926003915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926003915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:36:50Z","timestamp":1790152610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885926003915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":205,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0198885926003915"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2026.112045","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alopecia areata: An autoimmune insult, molecular insights, and therapeutic horizons","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2026.112045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112045"}}